Analyst Price Target is $110.50
▲ +34.77% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Medifast in the last 3 months. The average price target is $110.50, with a high forecast of $150.00 and a low forecast of $71.00. The average price target represents a 34.77% upside from the last price of $81.99.
Current Consensus is
The current consensus among 2 contributing investment analysts is to hold stock in Medifast. This rating has held steady since April 2022, when it changed from a Buy consensus rating.
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.